Search - tctmd.com

Displaying 501 - 520 of 604

Sort: Relevancy | Date

News Daily News

Survival Better, No ‘Risk Creep’ for TAVR vs Surgery in Lower-Risk Patients

L.A. McKeown

August 24, 2016

News Daily News

基因检测不一定是 HCM 诊断的最后一根稻草

Yael L. Maxwell

August 23, 2016

News Daily News

Las Pruebas Genéticas No son Necesariamente la Prueba Concluyente en el Diagnóstico de la CMH

Yael L. Maxwell

August 23, 2016

News Daily News

Genetic Testing Not Necessarily the Nail in the Coffin for HCM Diagnosis

Yael L. Maxwell

August 23, 2016

News Daily News

Electronic Feedback to Cardiologists Reduces Number of ‘Rarely Appropriate’ TTEs

L.A. McKeown

August 15, 2016

News Daily News

Less Is Not Always More: Screening for Coronary Disease Underused in Patients With Heart Failure

Todd Neale

July 25, 2016

News Industry News

Capricor Therapeutics Reports Positive 12-Month Data from the DYNAMIC Clinical Trial

June 17, 2016

News Daily News

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

Shelley Wood

June 14, 2016

News Industry News

BioVentrix Announces Successful First-In-Man, Catheter-Based Endovascular Clinical Procedure

May 17, 2016

News Daily News

Patients With Low Aortic Valve Gradient May Be Less Likely to Reap TAVR’s Benefits

Todd Neale

May 16, 2016

News Industry News

BioVentrix Announces Successful First-In-Man, Catheter-Based Endovascular Clinical Procedure with Revivent-TC™ System for Heart Failure Treatment

May 16, 2016

News Daily News

Sluggish CMS Reimbursement Lags Cardiac Device Approvals: Should Value Endpoints be Added to Trials?

Yael L. Maxwell

May 02, 2016

News Daily News

Evidence Does Not Support Widespread Preparticipation ECG Screening in Young Athletes

Michael O'Riordan

April 22, 2016

News Daily News

Fatal Cardiac Events No Higher With Aromatase Inhibitors for Breast Cancer Therapy

L.A. McKeown

April 21, 2016

News Industry News

CardioCell Completes Enrollment for a Phase IIa Clinical Trial Using Its Stem Cells for Participants With Chronic Heart Failure

April 19, 2016

News Conference News ACC 2016

CABG Beats Medical Therapy in CAD Patients With Severe LV Dysfunction: STICH 10-Year Results

Shelley Wood

April 08, 2016

News Conference News ACC 2016

Older Men With Existing Coronary Disease at Highest Risk of Dying During a Triathlon

Michael O'Riordan

April 06, 2016

News Conference News ACC 2016

‘Enhanced’ Multicellular Stem Cell Therapy Improves Clinical Outcomes in Heart Failure: ixCELL-DCM Study

Michael O'Riordan

April 04, 2016

News Conference News ACC 2016

When Chosen Wisely, 90-Year-Olds Do Well After TAVR

Caitlin E. Cox

April 02, 2016

News Daily News

AHA Issues Statement on Wearable Defibrillators, Cautions That Effectiveness Data Are Limited

Michael O'Riordan

March 31, 2016

Advertisement

Survival Better, No ‘Risk Creep’ for TAVR vs Surgery in Lower-Risk Patients

基因检测不一定是 HCM 诊断的最后一根稻草

Las Pruebas Genéticas No son Necesariamente la Prueba Concluyente en el Diagnóstico de la CMH

Genetic Testing Not Necessarily the Nail in the Coffin for HCM Diagnosis

Electronic Feedback to Cardiologists Reduces Number of ‘Rarely Appropriate’ TTEs

Less Is Not Always More: Screening for Coronary Disease Underused in Patients With Heart Failure

Capricor Therapeutics Reports Positive 12-Month Data from the DYNAMIC Clinical Trial

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

BioVentrix Announces Successful First-In-Man, Catheter-Based Endovascular Clinical Procedure

Patients With Low Aortic Valve Gradient May Be Less Likely to Reap TAVR’s Benefits

BioVentrix Announces Successful First-In-Man, Catheter-Based Endovascular Clinical Procedure with Revivent-TC™ System for Heart Failure Treatment

Sluggish CMS Reimbursement Lags Cardiac Device Approvals: Should Value Endpoints be Added to Trials?

Evidence Does Not Support Widespread Preparticipation ECG Screening in Young Athletes

Fatal Cardiac Events No Higher With Aromatase Inhibitors for Breast Cancer Therapy

CardioCell Completes Enrollment for a Phase IIa Clinical Trial Using Its Stem Cells for Participants With Chronic Heart Failure

CABG Beats Medical Therapy in CAD Patients With Severe LV Dysfunction: STICH 10-Year Results

Older Men With Existing Coronary Disease at Highest Risk of Dying During a Triathlon

‘Enhanced’ Multicellular Stem Cell Therapy Improves Clinical Outcomes in Heart Failure: ixCELL-DCM Study

When Chosen Wisely, 90-Year-Olds Do Well After TAVR

AHA Issues Statement on Wearable Defibrillators, Cautions That Effectiveness Data Are Limited

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content